Results 141 to 150 of about 103,562 (296)
Optimal management of subfertility in polycystic ovary syndrome
Joshua J Berger, G Wright Bates JrUniversity of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Birmingham, AL, USAAbstract: The purpose of this paper is to provide a stepwise ...
Berger JJ, Bates Jr GW
doaj
Physiological Basis of Sex Differences in Human Performance and Exercise‐Associated Pathology
ABSTRACT The presence of sex differences in human physical performance is well‐established and shaped by distinct endocrine, anatomical and physiological mechanisms. Despite sustained advances, our understanding of how inherent biological factors drive variations in exercise capacity and related pathologies is still developing.
David A. Holdsworth +7 more
wiley +1 more source
Obesity in Classic Congenital Adrenal Hyperplasia: Mechanisms, Complications and Management
ABSTRACT Classic congenital adrenal hyperplasia (CCAH) is an autosomal recessive genetic disorder primarily caused by 21‐hydroxylase deficiency. Although the survival rate of patients has significantly improved with glucocorticoid replacement therapy, long‐term use of supraphysiological doses and multiple factors inherent to the disease itself have led
Jialin Mu +5 more
wiley +1 more source
In a DHEA+HFD‐induced mouse model, Ins/BBR alleviated mitochondrial defects and broadly reprogrammed metabolic landscape in granulosa cells, in specific, restoring nucleotide pools and amino acid turnover, and preventing abnormal long‐chain fatty acid accumulation.
Juan Ge +8 more
wiley +1 more source
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dual GIP/GLP‐1 RAs are widely used to manage obesity, prediabetes and type 2 diabetes, typically in combination with lifestyle interventions. Their nutritional implications, however, remain unclear.
Rayanne Santos de Paulo +3 more
wiley +1 more source
Objective – to determine the ovarian reserve in women of reproductive age with PCOS, depending on the phenotype. Materials and methods. 60 women of reproductive age with and without polycystic ovary syndrome were included in the study.
Светлана Ивановна Елгина +1 more
doaj
Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? [PDF]
Talbott, EO
core +1 more source
ABSTRACT Background More than 12% of women worldwide are affected by polycystic ovary syndrome (PCOS), whose symptoms are similar to those of puberty, often leading to delayed diagnosis and missing the opportunity for early intervention. This not only puts PCOS women under physical and mental stress but also reduces their trust in doctors and makes ...
Baoying Zhang, Joan Lalor
wiley +1 more source
Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Alexander Nast +22 more
wiley +1 more source
FEATURES OF METABOLIC SYNDROME IN WOMEN OF EARLY REPRODUCTIVE AGE WITH POLYCYSTIC ОVARY SYNDROME
Aim. To determine the features of metabolic syndrome in women of early reproductive age with polycystic ovary syndrome. Materials and Methods. We recruited 60 consecutive women of early reproductive age, further dividing them into the groups with and ...
ANZHELIKA Y. Beglova +3 more
doaj

